Continue reading with a subscription.
A subscription is required for you to read this article in full. If you are a subscriber, you may log in to continue reading.
If you are at an institution or library and believe you should have access, please check with your librarian or administrator (more information).
Published in Volume 120, Issue 1
(January 4, 2010)
J. Clin. Invest.
120(1): 60-70 (2010).
doi:10.1172/JCI41158.
Copyright © 2010, The American Society for Clinical Investigation
Review Series
Enabling stem cell therapies through synthetic stem cell–niche engineering
Raheem Peerani, Peter W. Zandstra
Published
January 4, 2010
Enabling stem cell–targeted therapies requires an understanding of how to create local microenvironments (niches) that stimulate endogenous stem cells or serve as a platform to receive and guide the integration of transplanted stem cells and their derivatives. In vivo, the stem cell niche is a complex and dynamic unit. Although components of the in vivo niche continue to be described for many stem cell systems, how these components interact to modulate stem cell fate is only beginning to be understood. Using the HSC niche as a model, we discuss here microscale engineering strategies capable of systematically examining and reconstructing individual niche components. Synthetic stem cell–niche engineering may form a new foundation for regenerative therapies.